November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
The phase III NETTER-2 trial published in The Lancet and presented by Pamela Kunz at ASCO24 – Yale Cancer Center
Jun 10, 2024, 07:25

The phase III NETTER-2 trial published in The Lancet and presented by Pamela Kunz at ASCO24 – Yale Cancer Center

Yale Cancer Center shared a post on X:

“The phase III NETTER-2 trial published in The Lancet and presented by Pamela Kunz at ASCO24 showed Lu-Dotatate should be considered a new standard of care in 1st line therapy for pts with grade 2 or 3 advanced gastroenteropancreatic neuroendocrinetumors.”

Additional information.
Source: Yale Cancer Center/X